Evidence map›Paper›PMID 21740911›Full record

ArticleJournal of molecular and cellular cardiology2012

Caveolae compartmentalise β2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte.

David A Macdougall, Shailesh R Agarwal, Elizabeth A Stopford, Hongjin Chu, Jennifer A Collins, Anna L Longster, John Colyer, Robert D Harvey, Sarah Calaghan

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Article
  3. βNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Cholesterol inhibits assembly and activation of the EphA2 receptor.bioRxiv : the preprint server for biology · 2024
    Article
  9. Microtubule-Mediated Regulation of βCirculation research · 2023
    Article
  10. Caveolae-associated cAMP/CaJournal of molecular and cellular cardiology · 2023
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Compartmentation of βBritish journal of pharmacology · 2021
    Article
  17. βeLife · 2020
    Article
  18. Studying signal compartmentation in adult cardiomyocytes.Biochemical Society transactions · 2020
    Review
  19. βCirculation research · 2019
    Article
  20. Caveolin-3 KO disrupts t-tubule structure and decreases t-tubular IAmerican journal of physiology. Heart and circulatory physiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

David A MacdougallInstitute of Membrane and Systems Biology, University of Leeds, Leeds, LS2 9JT, UK.
Shailesh R Agarwal
Elizabeth A Stopford
Hongjin Chu
Jennifer A Collins
Anna L Longster
John Colyer
Robert D Harvey
Sarah Calaghan
University of Leeds · GBUniversity of Nevada, Reno · US

Funding

Mechanisms of cAMP CompartmentationR01GM101928 · NIGMS · UNIVERSITY OF NEVADA RENO · PI HARVEY, ROBERT D · 2012 to 2015
$1.1M
Medical Research Council G0700889NIGMS NIH HHS R01 GM101928
6 · The paper itself

Abstract

Inotropy and lusitropy in the ventricular myocyte can be efficiently induced by activation of β1-, but not β2-, adrenoceptors (ARs). Compartmentation of β2-AR-derived cAMP-dependent signalling underlies this functional discrepancy. Here we investigate the mechanism by which caveolae (specialised sarcolemmal invaginations rich in cholesterol and caveolin-3) contribute to compartmentation in the adult rat ventricular myocyte. Selective activation of β2-ARs (with zinterol/CGP20712A) produced little contractile response in control cells but pronounced inotropic and lusitropic responses in cells treated with the cholesterol-depleting agent methyl-β-cyclodextrin (MBCD). This was not linked to modulation of L-type Ca(2+) current, but instead to a discrete PKA-mediated phosphorylation of phospholamban at Ser(16). Application of a cell-permeable inhibitor of caveolin-3 scaffolding interactions mimicked the effect of MBCD on phosphorylated phospholamban (pPLB) during β2-AR stimulation, consistent with MBCD acting via caveolae. Biosensor experiments revealed β2-AR mobilisation of cAMP in PKA II signalling domains of intact cells only after MBCD treatment, providing a real-time demonstration of cAMP freed from caveolar constraint. Other proteins have roles in compartmentation, so the effects of phosphodiesterase (PDE), protein phosphatase (PP) and phosphoinositide-3-kinase (PI3K) inhibitors on pPLB and contraction were compared in control and MBCD treated cells. PP inhibition alone was conspicuous in showing robust de-compartmentation of β2-AR-derived signalling in control cells and a comparatively diminutive effect after cholesterol depletion. Collating all evidence, we promote the novel concept that caveolae limit β2-AR-cAMP signalling by providing a platform that not only attenuates production of cAMP but also prevents inhibitory modulation of PPs at the sarcoplasmic reticulum. This article is part of a Special Issue entitled "Local Signaling in Myocytes".

Indexed as

Signal TransductionAnimalsbeta-CyclodextrinsCalciumCaveolaeCells, CulturedChromonesCyclic AMPHeart VentriclesMaleMorpholinesMyocardial ContractionMyocytes, CardiacPhosphoinositide-3 Kinase InhibitorsPhosphoric Monoester HydrolasesPhosphorylation2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-onebeta-CyclodextrinsCalciumChromonesCyclic AMPmethyl-beta-cyclodextrinMorpholinesPhosphoinositide-3 Kinase InhibitorsPhosphoric Monoester HydrolasesReceptors, Adrenergic, beta-2

Identifiers

PMID21740911
PMCPMC3270222
OpenAlexW2025454491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.